These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8978063)
1. Genetic evaluation of candidate genes for the Mom1 modifier of intestinal neoplasia in mice. Gould KA; Luongo C; Moser AR; McNeley MK; Borenstein N; Shedlovsky A; Dove WF; Hong K; Dietrich WF; Lander ES Genetics; 1996 Dec; 144(4):1777-85. PubMed ID: 8978063 [TBL] [Abstract][Full Text] [Related]
2. Localized gene action controlling intestinal neoplasia in mice. Gould KA; Dove WF Proc Natl Acad Sci U S A; 1997 May; 94(11):5848-53. PubMed ID: 9159163 [TBL] [Abstract][Full Text] [Related]
3. Genetic basis of variation in adenoma multiplicity in ApcMin/+ Mom1S mice. Haines J; Johnson V; Pack K; Suraweera N; Slijepcevic P; Cabuy E; Coster M; Ilyas M; Wilding J; Sieber O; Bodmer W; Tomlinson I; Silver A Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2868-73. PubMed ID: 15710876 [TBL] [Abstract][Full Text] [Related]
4. Analysis of the Mom1 modifier of intestinal neoplasia in mice. Gould KA; Dove WF Exp Lung Res; 1998; 24(4):437-53. PubMed ID: 9659576 [TBL] [Abstract][Full Text] [Related]
5. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia. MacPhee M; Chepenik KP; Liddell RA; Nelson KK; Siracusa LD; Buchberg AM Cell; 1995 Jun; 81(6):957-66. PubMed ID: 7781071 [TBL] [Abstract][Full Text] [Related]
6. The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions. Dove WF; Cormier RT; Gould KA; Halberg RB; Merritt AJ; Newton MA; Shoemaker AR Philos Trans R Soc Lond B Biol Sci; 1998 Jun; 353(1370):915-23. PubMed ID: 9684289 [TBL] [Abstract][Full Text] [Related]
7. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Cormier RT; Hong KH; Halberg RB; Hawkins TL; Richardson P; Mulherkar R; Dove WF; Lander ES Nat Genet; 1997 Sep; 17(1):88-91. PubMed ID: 9288104 [TBL] [Abstract][Full Text] [Related]
8. Mom1 is a semi-dominant modifier of intestinal adenoma size and multiplicity in Min/+ mice. Gould KA; Dietrich WF; Borenstein N; Lander ES; Dove WF Genetics; 1996 Dec; 144(4):1769-76. PubMed ID: 8978062 [TBL] [Abstract][Full Text] [Related]
9. Action of Min and Mom1 on neoplasia in ectopic intestinal grafts. Gould KA; Dove WF Cell Growth Differ; 1996 Oct; 7(10):1361-8. PubMed ID: 8891340 [TBL] [Abstract][Full Text] [Related]
10. Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia. Silverman KA; Koratkar R; Siracusa LD; Buchberg AM Genome Res; 2002 Jan; 12(1):88-97. PubMed ID: 11779834 [TBL] [Abstract][Full Text] [Related]
11. Loss of Apc+ in intestinal adenomas from Min mice. Luongo C; Moser AR; Gledhill S; Dove WF Cancer Res; 1994 Nov; 54(22):5947-52. PubMed ID: 7954427 [TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity in spontaneous and X-ray-induced intestinal tumors arising in F1 hybrid min mice: evidence for sequential loss of APC(+) and Dpc4 in tumor development. Haines J; Dunford R; Moody J; Ellender M; Cox R; Silver A Genes Chromosomes Cancer; 2000 Aug; 28(4):387-94. PubMed ID: 10862047 [TBL] [Abstract][Full Text] [Related]
13. The CAST/Ei strain confers significant protection against Apc(Min) intestinal polyps, independent of the resistant modifier of Min 1 (Mom1) locus. Koratkar R; Pequignot E; Hauck WW; Siracusa LD Cancer Res; 2002 Oct; 62(19):5413-7. PubMed ID: 12359746 [TBL] [Abstract][Full Text] [Related]
14. Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers. Halberg RB; Katzung DS; Hoff PD; Moser AR; Cole CE; Lubet RA; Donehower LA; Jacoby RF; Dove WF Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3461-6. PubMed ID: 10716720 [TBL] [Abstract][Full Text] [Related]
15. A resistant genetic background leading to incomplete penetrance of intestinal neoplasia and reduced loss of heterozygosity in ApcMin/+ mice. Shoemaker AR; Moser AR; Midgley CA; Clipson L; Newton MA; Dove WF Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10826-31. PubMed ID: 9724789 [TBL] [Abstract][Full Text] [Related]
16. The Mom1AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64. Cormier RT; Bilger A; Lillich AJ; Halberg RB; Hong KH; Gould KA; Borenstein N; Lander ES; Dove WF Oncogene; 2000 Jun; 19(28):3182-92. PubMed ID: 10918573 [TBL] [Abstract][Full Text] [Related]
17. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice. Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP Cancer Res; 2004 Dec; 64(24):8876-81. PubMed ID: 15604247 [TBL] [Abstract][Full Text] [Related]